Baxter, H, Winder, R, Chalder, M, Wright, C, Sherlock, S, Haase, AM, Wiles, NJ, Montgomery, AA, Taylor, AH, Fox, KR, Lawlor, DA, Peters, TJ, Sharp, D, Campbell, J, Lewis, G (2010). Physical activity as a treatment for depression: the TREAD randomized controlled trial protocol. Trials
Beck, A, Steer, RA, Brown, GK (1996). Manual for the Beck Depression Inventory –Second Edition. The Psychological Corporation: San Antonio, TX.
Cipriani, A, Furukawa, TA, Salanti, G, Geddes, JR, Higgins, JPT, Churchill, R, Watanabe, N, Nakagawa, A, Omori, IM, McGuire, H, Tansella, M, Barbui, C (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet
Dunn, G, Maracy, M, Dowrick, C, Ayuso-Mateos, JL, Dalgard, OS, Page, H, Lehtinen, V, Casey, P, Wilkinson, C, Vázquez-Barquero, JL, Wilkinson, G; ODIN group (2003). Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up. British Journal of Psychiatry
Eyding, D, Leigemann, M, Grouven, U, Harter, M, Kromp, M, Kaiser, T, Kerekes, MF, Gerken, M, Wieseler, B (2010). Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. British Medical Journal
Fischer, K, Goetghebeur, E, Vrijens, B, White, IR (2011). A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments. Biostatistics
Fleming, TR (2008). Current issues in non-inferiority trials. Statistics in Medicine
Freemantle, N, Anderson, IM, Young, P (2000). Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. British Journal of Psychiatry
Gordon, D, Levitas, R, Pantazis, C, Payne, S, Townsend, P, Adelman, L, Ashworth, K, Middleton, S, Bradshaw, J, Williams, J (2000). Poverty and Social Exclusion Survey of Britain Questionnaire. Joseph Rowntree Foundation: York.
Hill, SA, Taylor, MJ, Harmer, CJ, Cowen, PJ (2003). Acute reboxetine administration increases plasma and salivary cortisol. Journal of Psychopharmacology
HSCIC (2012). Prescription Cost Analysis – England, 2011. Health and Social Care Information Centre: London.
Jenkinson, C, Layte, R (1997). Development and testing of the UK SF-12 (short form health survey). Journal of Health Services Research and Policy
John, OP, Donahue, EM, Kentle, RL (1991). The ‘Big Five’ Inventory – versions 4a and 54. Institute of Personality and Social Research, University of California, Berkeley: Berkeley, CA.
Jones, B, Jarvis, P, Lewis, J, Ebbutt, A (1996). Trials to assess equivalence: the importance of rigorous methods. British Medical Journal
Last, JM (1995). A Dictionary of Epidemiology. Oxford University Press: Oxford.
Lewis, G (1994). Assessing psychiatric disorder with a human interviewer or a computer. Journal of Epidemiology and Community Health
Lewis, G, Mulligan, J, Wiles, N, Cowen, PJ, Craddock, N, Ikeda, M, Grozeva, D, Mason, V, Nutt, DJ, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Peters, TJ (2011). The 5HT transporter polymorphism and response to antidepresants: a randomized controlled trial. British Journal of Psychiatry
Lewis, G, Pelosi, AJ, Araya, R, Dunn, G (1992). Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychological Medicine
Meyer, JH, Wilson, AA, Ginovart, N, Goulding, V, Hussey, D, Hood, K, Houle, S (2001). Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [11C]DASB PET imaging study. American Journal of Psychiatry
Papakostas, GI, Nelson, JC, Kasper, S, Moller, H-J (2008). A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. European Neuropsychopharmacology
Piccinelli, M, Tessari, E, Bortolomasi, M, Piasere, O, Semenzin, M, Garzotto, N, Tansella, M (1997). Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. British Medical Journal
Robins, JM (1994). Correcting for non-compliance in randomized trials using structural nested mean models. Communications in Statistics – Theory and Methods
Robins, JM, Tsiatis, AA (1991). Correcting for non-compliance in randomized trials using rank preserving structural failure time models. Communications in Statistics – Theory and Methods
Szabadi, E, Bradshaw, CM, Boston, PF, Langley, RW (1998). The human pharmacology of reboxetine. Human Psychopharmacology
Thomas, L, Mulligan, J, Mason, V, Tallon, D, Wiles, N, Cowen, PJ, Nutt, DJ, O'Donovan, M, Sharp, D, Peters, T, Lewis, G (2008). Genetic and clinical predictors of treatment response in depression: the GENPOD randomized trial protocol. Trials
Vansteelandt, S, Goetghebeur, E (2003). Causal inference with generalized structural mean models. Journal of the Royal Statistical Society: Series B (Statistical Methodology)
White, IR, Kalaitzaki, R, Thompson, SG (2011). Allowing for missing outcome data and incomplete uptake of randomized interventions, with application to an internet-based alcohol trial. Statistics in Medicine
Wiles, NJ, Mulligan, J, Peters, TJ, Cowen, PJ, Mason, V, Nutt, DJ, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Lewis, G (2012). Severity of depression and response to antidepressants: the GENPOD randomised controlled trial. British Journal of Psychiatry
Zigmond, AS, Snaith, RP (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica